GEN Exclusives

More »

GEN Poll

More »
May 13, 2013

Genome Sequencing and Patient Autonomy

In a dramatic shift away from the patient’s “right-not-to-know” message pervading clinical genetics since the field’s inception, new guidelines issued by American College of Medical Genetics and Genomics suggest that anyone undergoing genome sequencing for any reason should also be screened for dozens of variants associated with life-threatening but treatable conditions. (Read more about the new guidelines here.) What are your thoughts on this?

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Yes
 
  42.9%
No
 
  36.7%
Undecided
 
  20.4%

More Polls » View Results »

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Tackling Climate Change

Do you think most companies will respond positively to the People’s Climate March?